Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Akoya BioSciences, Inc. (AKYA)
Company Research
Source: GlobeNewswire
MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ending December 31, 2024. "Akoya navigated a challenging 2024 in the life science tools market, which was constrained by subdued capital equipment purchases, by successfully strengthening gross margins, reducing operating expenses and advancing our companion diagnostics programs throughout the year. We remain optimistic about the long-term growth outlook of Akoya’s leading spatial biology solutions," said Brian McKelligon, CEO of Akoya. "In 2024, Akoya achieved multiple milestones, including expanding our market-le
Read more
Impact Snapshot
Event Time:
AKYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKYA alerts
High impacting Akoya BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
AKYA
News
- Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $1.80 price target on the stock, down previously from $3.50.MarketBeat
- Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $3.50 price target on the stock.MarketBeat
- Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.MarketBeat
- Nuclera Appoints Seth Benson as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology PanelsGlobeNewswire
AKYA
Earnings
- 3/17/25 - Miss
AKYA
Sec Filings
- 3/25/25 - Form 4
- 3/25/25 - Form 4
- 3/18/25 - Form 425
- AKYA's page on the SEC website